BAB, Inc.
BABB· OTC
BABBBAB, Inc.
Filed Jul 13, 2026 · 10-Q · 43 days after period end · 0001437749-26-023420
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $803.69K | $808.49K | $882.84K | $864.40K |
| Net Income | $186.88K | $154.29K | $145.69K | $126.53K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BAB, Inc. · CIK 1123596 · Engraved from SEC EDGAR
ended May 31, 2026 · filed Jul 13, 2026 · 43 d after period end
